array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(659)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(97) "Hartford Investment Management Co. Has $452,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(249) "Hartford Investment Management Co. lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC)."
["url"]=>
string(134) "https://www.defenseworld.net/2024/04/08/hartford-investment-management-co-has-452000-position-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/90fd6be9-d94a-403b-9ecd-b42236ac8bbd"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-04-08"
["categories"]=>
array(4) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(18) "General Investment"
[2]=>
string(9) "Valuation"
[3]=>
string(11) "Regulations"
}
}
[1]=>
array(7) {
["title_en"]=>
string(90) "Tudor Investment Corp Et Al Invests $2.53 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(287) "Tudor Investment Corp Et Al purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 7,055 shares of the medical research company’s stock, valued at approximately $2,529,000."
["url"]=>
string(129) "https://www.defenseworld.net/2024/03/14/tudor-investment-corp-et-al-invests-2-53-million-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e1303b75-d719-46b0-9197-7c67e7b48c05"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-03-14"
["categories"]=>
array(7) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(19) "Investment Requests"
[3]=>
string(13) "Credit Rating"
[4]=>
string(12) "Stock Market"
[5]=>
string(18) "General Investment"
[6]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(73) "Scope Fluidics (WSE:SCP) - Stock Price, News & Analysis - Simply Wall St"
["snippet_en"]=>
string(155) "Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more."
["url"]=>
string(72) "https://simplywall.st/stocks/pl/healthcare/wse-scp/scope-fluidics-shares"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6d70ed64-378e-46e9-bb90-37dead2c5896"
["source"]=>
string(13) "simplywall.st"
["publication_date"]=>
string(10) "2024-02-26"
["categories"]=>
array(5) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(15) "Market Movement"
[2]=>
string(12) "Stock Market"
[3]=>
string(18) "General Investment"
[4]=>
string(9) "Valuation"
}
}
[3]=>
array(7) {
["title_en"]=>
string(74) "Bio-Rad Laboratories Reports Strong Sartorius AG Financials - TipRanks.com"
["snippet_en"]=>
string(167) "Bio-Rad Laboratories (BIO) has released an update. Bio-Rad Laboratories, Inc. has shared an update on its investment in Sartorius AG, revealing key financial figure..."
["url"]=>
string(111) "https://www.tipranks.com/news/company-announcements/bio-rad-laboratories-reports-strong-sartorius-ag-financials"
["image_url"]=>
NULL
["source"]=>
string(12) "tipranks.com"
["publication_date"]=>
string(10) "2024-02-21"
["categories"]=>
array(1) {
[0]=>
string(18) "General Investment"
}
}
[4]=>
array(7) {
["title_en"]=>
string(41) "SPY ETF Update, 12/4/2023 - TipRanks.com"
["snippet_en"]=>
string(163) "How is SPY stock faring? The SPDR SP 500 ETF Trust (SPY) is up 0.25% in the past 5 days and has risen 21.9% year-to-date. According to TipRanks’ unique ETF
string(54) "https://www.tipranks.com/news/spy-etf-update-4-12-2023"
["image_url"]=>
NULL
["source"]=>
string(12) "tipranks.com"
["publication_date"]=>
string(10) "2023-12-04"
["categories"]=>
array(1) {
[0]=>
string(18) "General Investment"
}
}
[5]=>
array(7) {
["title_en"]=>
string(88) "Private Advisor Group LLC Has $234,000 Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(231) "Private Advisor Group LLC increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission."
["url"]=>
string(126) "https://www.defenseworld.net/2023/12/03/private-advisor-group-llc-has-234000-holdings-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/22e3d56b-b7d5-4b29-a3d6-33ac65de01b1"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-12-03"
["categories"]=>
array(6) {
[0]=>
string(11) "Regulations"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(20) "Corporate Governance"
[3]=>
string(18) "General Investment"
[4]=>
string(9) "Valuation"
[5]=>
string(11) "Acquisition"
}
}
[6]=>
array(7) {
["title_en"]=>
string(62) "Investors are worried about growing volatility | Investing.com"
["snippet_en"]=>
string(143) "Alexey Kalachev: market overview, including XAU/USD, S&P 500, Dow Jones Industrial Average, Nikkei 225. Latest market analysis on Investing.com"
["url"]=>
string(51) "https://ru.investing.com/analysis/article-200308103"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2023-10-18"
["categories"]=>
array(12) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(5) "Debts"
[2]=>
string(15) "Market Movement"
[3]=>
string(14) "Issuing Shares"
[4]=>
string(31) "Financial Update/Profit Warning"
[5]=>
string(19) "Investment Requests"
[6]=>
string(16) "Share Repurchase"
[7]=>
string(25) "Business Model Resilience"
[8]=>
string(24) "Quarterly/Annual Figures"
[9]=>
string(12) "Stock Market"
[10]=>
string(18) "General Investment"
[11]=>
string(11) "Acquisition"
}
}
[7]=>
array(7) {
["title_en"]=>
string(124) "S&P 500 stock Bio-Rad Laboratories share: This is how much loss an early investment in Bio-Rad Laboratories would have meant"
["snippet_en"]=>
string(88) "Investors would have to take that much loss on an early Bio-Rad Laboratories investment."
["url"]=>
string(173) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-titel-bio-rad-laboratories-aktie-so-viel-verlust-haette-ein-fruehes-investment-in-bio-rad-laboratories-bedeutet-1032670689"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c4adea6e-d05d-414a-9f75-a83bfe71764e"
["source"]=>
string(11) "finanzen.ch"
["publication_date"]=>
string(10) "2023-10-02"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(18) "General Investment"
}
}
[8]=>
array(7) {
["title_en"]=>
string(125) "S&P 500 paper Bio-Rad Laboratories share: This is how much profit an early Bio-Rad Laboratories investment would have brought"
["snippet_en"]=>
string(88) "Invested in Bio-Rad Laboratories years ago: That's how much investors would have earned."
["url"]=>
string(174) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-papier-bio-rad-laboratories-aktie-so-viel-gewinn-haette-eine-fruehe-bio-rad-laboratories-investition-eingebracht-1032637282"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c88e0eed-05ab-4928-82b1-85b90a42b1f2"
["source"]=>
string(11) "finanzen.ch"
["publication_date"]=>
string(10) "2023-09-18"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(12) "Stock Market"
[2]=>
string(18) "General Investment"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
659 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Hartford Investment Management Co. lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).
Tudor Investment Corp Et Al purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 7,055 shares of the medical research company’s stock, valued at approximately $2,529,000.
Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Bio-Rad Laboratories (BIO) has released an update. Bio-Rad Laboratories, Inc. has shared an update on its investment in Sartorius AG, revealing key financial figure...
How is SPY stock faring? The SPDR SP 500 ETF Trust (SPY) is up 0.25% in the past 5 days and has risen 21.9% year-to-date. According to TipRanks’ unique ETF</...
Private Advisor Group LLC increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.